Key points
A narrow, evidence-based reading
- Match the material name, presentation, and lot number before reading test results.
- Read the method, acceptance criterion, and result as three separate fields.
- Treat a COA as documented evidence—not as a universal claim of suitability.
Start with document identity
The first task is traceability. The name and lot or batch number on the certificate should match the label and receiving record for the material being reviewed. A polished report that cannot be connected to the physical container is not lot-specific evidence for that container.
Also note who issued the document, the date of testing or release, and any document or revision number. If testing was performed by a separate laboratory, the report should make the relationship between the supplier, laboratory, sample, and lot understandable.
- Material
- Name, form, stated amount, and any catalog identifier.
- Traceability
- Lot or batch number that matches the container and receiving record.
- Document control
- Issue date, report number, revision, and authorized approval when provided.
Read the analytical table in columns
A useful analytical table identifies what was tested, which procedure was used, what limit or specification applied, and what result was obtained. Those fields should not be collapsed into a single percentage or a pass label.
For example, a chromatographic purity result and a mass-spectrometric identity result answer different questions. The presence of one does not silently supply the other. Method names should be specific enough to understand the evidence being presented.
- Test
- The characteristic being examined, such as identity, chromatographic purity, or water content.
- Procedure
- The named or referenced analytical method used to generate the result.
- Acceptance criterion
- The predefined limit or range against which the result was evaluated.
- Result
- The observed value or qualitative finding for that lot.
Keep identity, purity, and amount separate
Identity asks whether the measured material is consistent with the named substance. Purity describes the relative presence of the main component under a specified analytical approach. Assay or content addresses how much of a material is present. These are related but non-interchangeable questions.
A high area-percent result from one chromatographic run does not by itself establish molecular identity, amount per vial, sterility, endotoxin status, or stability. Those conclusions require their own appropriate evidence.
Check dates, status, and open questions
Record the test date, release date, retest date, or expiry date exactly as labeled. Do not infer a shelf life from the age of the document. A supported period depends on stability information and stated storage conditions, not on the appearance of the vial or powder.
If the document omits the lot number, procedure, result, units, acceptance criterion, or issuing organization, record the gap and request clarification. An unanswered question should remain an unanswered question rather than being filled with an assumption.
- Ask
- Does this certificate belong to this exact lot?
- Ask
- Can each reported result be connected to a named procedure and unit?
- Ask
- Which important characteristics were not evaluated or not reported?
What this guide does not establish
This guide explains how to organize a document review. It does not certify any supplier, laboratory, material, method, or lot, and it is not a substitute for an institution's quality system or a qualified analytical review.
Beach Bio Research catalog items remain limited to qualified laboratory, analytical, and educational research. A certificate of analysis does not convert a research material into a product for human or veterinary use.
Primary references
Source notes
These references provide analytical and documentation context. Citing them does not claim that Beach Bio Research catalog items are approved products or that the cited regulatory frameworks apply to a particular catalog item.
- Q7A Good Manufacturing Practice Guidance for Active Pharmaceutical IngredientsU.S. Food and Drug Administration. Includes a detailed description of information commonly recorded on certificates of analysis.
- Q6A Specifications: Test Procedures and Acceptance CriteriaU.S. Food and Drug Administration. Discusses identification, test procedures, specifications, and acceptance criteria.
- Q2(R2) Validation of Analytical ProceduresU.S. Food and Drug Administration. General framework for analytical-procedure validation and performance characteristics.